cutaneous leishmaniaisis. Cutaneous leishmaniasis
Conditions
Interventions
Intervention 1: Intervention group A: Patients were given drug via Intravenous route. The drug should be given diluted in 50–200 ml of 5% glucose solution over 30–60 minutes in ICU/HDU with cardiac mo
Sponsors
CMH Quetta
Eligibility
Sex/Gender
All
Age
15 Years to 80 Years
Inclusion criteria
Inclusion criteria: All patients with biopsy proven leishmaniasis plus any of the following: has lesion(s) located in sites not compatible with local treatment for example eyelids lesions in which scaring would be disabling or severely disfiguring like on face lesions that will have difficulting in healing like on lower limb or over a joint lesions involving mucosa or cartilage lesion =4 cm lesion with sporotrichoid spread multiple lesions
Exclusion criteria
Exclusion criteria: patients allergic to antimonials the lesion is already self-curing pregnant and breast feeding women those who refused to accept the diagnostic procedures patients having mucosal, mucocutaneous or visceral leishmaniasis Patients with comorbidity (diabetes, hypertension,chronic liver disease,chronic kidney disease) and/or immunosuppression Patients with baseline ECG abnormalities/Heart disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Healing of lesion in response to treatment. Timepoint: before intervention and 2, 4 , 6 and 8 weeks after intervention until complete healing occur than patient called for followup after 4 weeks. Method of measurement: Clinical Response Evaluation. | — |
Countries
Pakistan
Contacts
Public ContactDr. Shafia Shaikh
CMH Quetta
Outcome results
None listed